Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 3, 2006, Pages 230-238

  Morali, Giancarlo ^a   Polatti, Franco ^b   Metelitsa, Elena N ^c   Mascarucci, Paolo ^d   Magnani, Paola ^d   Marrè, Giovanni Brunenghi ^a  

^a VILLA SCASSI HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c DONETSK MEDICAL UNIVERSITY   (Ukraine)

^d Polichem SA   (Switzerland)

Author keywords

Gynaecological drugs; Humulus lupulus; Hyaluronic acid; Medical device; Menopause; Phytoestrogens; Vaginal atrophy; Vaginal dryness

Indexed keywords

ALPHA TOCOPHEROL; HUMULUS LUPULUS EXTRACT; HYALURONIC ACID; LIPOSOME; PHYTOESTROGEN;

ABRASION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; EDEMA; EPITHELIZATION; FEMALE; GEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL INSTRUMENTATION; MULTICENTER STUDY; PILOT STUDY; POSTMENOPAUSE; RASH; VAGINA ATROPHY; VAGINAL BURNING SENSATION; VAGINAL DRYNESS; VAGINAL PRURITUS; VAGINITIS; VISUAL ANALOG SCALE; VULVOVAGINITIS;

EID: 33645473323     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296715     Document Type: Article

References (11)

1. Zapantis, G., Santoro, N., The menopausal transition: characteristics and management. Best Pract. Res. Clin. Endocrinol. Metab. 17, 33 (2003)
2. Rozenberg, S., Pastijn, A., Gevers, R. et al., Estrogen therapy in older patients with recurrent urinary tract infections: a review. Int. J. Fertil. Womens Med. 49, 71 (2004)
3. Morris, E., Rymer, J., Menopausal symptoms. Clin. Evid. 13, 2392 (2005)
4. Van Lunsen, R. H., Laan, E., Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause 11 (6 Pt 2), 741 (2004)
5. Milsom, I., Rational prescribing for postmenopausal urogenital complaints. Drugs Aging 9, 78 (1996)
6. Prelevic, G. M., Kocjan, T., Markou, A., Hormone replacement therapy in postmenopausal women. Minerva Endocrinol. 30, 27 (2005)
7. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Centre for Drug Evaluation and Research (CDER), Guidance for industry. Bacterial vaginosis - Developing antimicrobial drugs for treatment. Draft Guidance (July 1998)
8. Brown, M. B., Jones, S. A., Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J. Eur. Acad. Dermatol. Venereol. 19, 308 (2005)
9. Stevens, J. F., Miranda, C. L., Wolthers, K. R. et al., Identification and in vitro biological activities of hop proanthocyanidins: inhibition of nNOS activity and scavenging of reactive nitrogen species. J. Agric. Food Chem. 50, 3435 (2002)
10. Milligan, S. R., Kalita, J. C., Heyerick, A. et al., Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 84, 2249 (1999)
11. Milligan, S. R., Kalita, J. C., Pockok, V. et al., The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 85, 4912 (2000)